Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization \n “,”tablet”:” Continued Progress Earns Financing to Accelerate \nCommercial Growth and Advancing Pipeline “,”phone”:” Continued Progress Earns Financing \nto Accelerate Commercial Growth and Advancing Pipeline “} },”slug”:”et_pb_text”}” data-et-multi-view-load-tablet-hidden=”true” data-et-multi-view-load-phone-hidden=”true”> CCM therapy is now indicated